UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013590
Receipt number R000015879
Scientific Title The evaluation of the efficacy and safety of Hainosankyuto on purulence in patients with lymphedema
Date of disclosure of the study information 2014/05/07
Last modified on 2018/01/29 09:20:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The evaluation of the efficacy and safety of Hainosankyuto on purulence in patients with lymphedema

Acronym

The effect of Hainosankyuto on purulence in patients with lymphedema

Scientific Title

The evaluation of the efficacy and safety of Hainosankyuto on purulence in patients with lymphedema

Scientific Title:Acronym

The effect of Hainosankyuto on purulence in patients with lymphedema

Region

Japan


Condition

Condition

Patients with lymphedema

Classification by specialty

Medicine in general Surgery in general Obstetrics and Gynecology
Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety on purulence in patients with lymphedema and to explore the action mechanism by clinical pharmacological testing of Hainosankyuto

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The number of days to clear the symptoms of purulence

Key secondary outcomes

1)The severity of the symptoms of purulence 2)The body temperature 3)QOL questionnaire 4)The circumference of the region of lymphedema (the affected side) 5)Immunologic test [Measuring NK cell activity, balance between Th1 and Th2, and cytokine (TNF-alpha, IL-12)]


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TSUMURA Hainosankyuto Extract Granules for Ethical Use plus oral antibiotics for two weeks

Interventions/Control_2

oral antibiotics for two weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Female

Key inclusion criteria

1)Patients with lymphedema
2)Patients diagnosed grade 2 and more in lymphedema staging according to International Society of Lymphedema (ISL)
3)Patients with a first episode of purulence or who relapsed after over a year
4)Patients within 3 days after the onset of purulence
5)20-75 years of age
6)Sex: Female
7)Outpatient
8)Patients with written consent

Key exclusion criteria

1)Patients with aldosteronism, myopathy and hypokalemia
2)Patients who were prescribed Kampo medicine within 4 weeks before entry
3)Patients who were prescribed an adrenocortical hormonic agent or an anti-allergic agent
4)Patients with serious complications (liver, kidney, heart, blood, or metabolic disorders)
5)Patients with recurrent or metastasized cancer
6)Pregnant patients, breast-feeding patients or patients hoping to become pregnant
7)Patients considered inappropriate by the study investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriaki Sakuragi

Organization

Hokkaido University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

North 15, West 7, Kitaku, Sapporo 060-8638, Japan

TEL

011-706-5941

Email

sakuragi@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Noriko Kobayashi

Organization

Hokkaido University Hospital

Division name

Gynecology

Zip code


Address

North 15, West 7, Kitaku, Sapporo 060-8638, Japan

TEL

011-706-5941

Homepage URL


Email

norikingyo@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

TSUMURA & CO.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 03 Month 25 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 01 Day

Last modified on

2018 Year 01 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015879


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name